Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(2.27)
# 2,883
Out of 4,371 analysts
159
Total ratings
45.3%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintained: Hold | $185 | $185.79 | -0.43% | 4 | Jun 3, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $19 | $14.06 | +35.14% | 1 | Jun 3, 2026 | |
| WST West Pharmaceutical Services | Rated: Hold | $315 → $325 | $317.32 | +2.42% | 8 | May 29, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $160 | $138.37 | +15.63% | 5 | May 28, 2026 | |
| GH Guardant Health | Maintained: Buy | $130 | $133.06 | -2.30% | 5 | May 27, 2026 | |
| HTFL HeartFlow | Maintained: Hold | $35 | $28.81 | +21.49% | 1 | May 15, 2026 | |
| MTD Mettler-Toledo International | Rated: Hold | $1,475 → $1,275 | $1,180.48 | +8.01% | 3 | May 12, 2026 | |
| VCYT Veracyte | Maintained: Sell | $37 | $49.94 | -25.91% | 4 | May 12, 2026 | |
| NTRA Natera | Maintained: Buy | $250 | $222.10 | +12.56% | 4 | May 12, 2026 | |
| PSNL Personalis | Rated: Hold | $10 → $9 | $12.10 | -25.62% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $18 | $18.08 | -0.44% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $22 | $33.50 | -34.33% | 4 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $18.51 | +2.65% | 8 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $5.5 | $4.33 | +27.02% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 | $66.55 | -9.84% | 5 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $52.26 | +33.95% | 4 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $350 | $376.47 | -7.03% | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $240 → $225 | $186.88 | +20.40% | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $670 → $620 | $482.03 | +28.62% | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $184 | $186.64 | -1.39% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $9.52 | +5.04% | 1 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $68 | $80.00 | -15.00% | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $182 | $42.19 | +331.38% | 12 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $160 | $107.51 | +48.82% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $3.41 | n/a | 11 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $3.69 | n/a | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $14.88 | n/a | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $260 | $320.63 | n/a | 12 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $11 | $7.92 | n/a | 4 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $4.60 | n/a | 14 | Dec 3, 2024 |
Charles River Laboratories International
Jun 3, 2026
Maintained: Hold
Price Target: $185
Current: $185.79
Upside: -0.43%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $19
Current: $14.06
Upside: +35.14%
West Pharmaceutical Services
May 29, 2026
Rated: Hold
Price Target: $315 → $325
Current: $317.32
Upside: +2.42%
Agilent Technologies
May 28, 2026
Reiterated: Buy
Price Target: $160
Current: $138.37
Upside: +15.63%
Guardant Health
May 27, 2026
Maintained: Buy
Price Target: $130
Current: $133.06
Upside: -2.30%
HeartFlow
May 15, 2026
Maintained: Hold
Price Target: $35
Current: $28.81
Upside: +21.49%
Mettler-Toledo International
May 12, 2026
Rated: Hold
Price Target: $1,475 → $1,275
Current: $1,180.48
Upside: +8.01%
Veracyte
May 12, 2026
Maintained: Sell
Price Target: $37
Current: $49.94
Upside: -25.91%
Natera
May 12, 2026
Maintained: Buy
Price Target: $250
Current: $222.10
Upside: +12.56%
Personalis
May 12, 2026
Rated: Hold
Price Target: $10 → $9
Current: $12.10
Upside: -25.62%
May 12, 2026
Maintained: Hold
Price Target: $21 → $18
Current: $18.08
Upside: -0.44%
May 12, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $33.50
Upside: -34.33%
May 12, 2026
Maintained: Hold
Price Target: $19
Current: $18.51
Upside: +2.65%
May 12, 2026
Rated: Hold
Price Target: $6 → $5.5
Current: $4.33
Upside: +27.02%
May 12, 2026
Maintained: Hold
Price Target: $60
Current: $66.55
Upside: -9.84%
May 12, 2026
Maintained: Buy
Price Target: $70
Current: $52.26
Upside: +33.95%
May 5, 2026
Maintained: Hold
Price Target: $350
Current: $376.47
Upside: -7.03%
May 5, 2026
Maintained: Buy
Price Target: $240 → $225
Current: $186.88
Upside: +20.40%
Apr 27, 2026
Rated: Buy
Price Target: $670 → $620
Current: $482.03
Upside: +28.62%
Apr 23, 2026
Rated: Buy
Price Target: $270 → $184
Current: $186.64
Upside: -1.39%
Feb 13, 2026
Maintained: Hold
Price Target: $10
Current: $9.52
Upside: +5.04%
Jul 15, 2025
Maintained: Buy
Price Target: $100 → $68
Current: $80.00
Upside: -15.00%
Jul 15, 2025
Maintained: Buy
Price Target: $200 → $182
Current: $42.19
Upside: +331.38%
Jun 11, 2025
Maintained: Buy
Price Target: $130 → $160
Current: $107.51
Upside: +48.82%
May 20, 2025
Maintained: Hold
Price Target: $20 → $15
Current: $3.41
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $10
Current: $3.69
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $19
Current: $14.88
Upside: n/a
Apr 24, 2025
Maintained: Hold
Price Target: $260
Current: $320.63
Upside: n/a
Feb 27, 2025
Maintained: Hold
Price Target: $10 → $11
Current: $7.92
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $4.60
Upside: n/a